Trial Profile
Phase III trial of ITV 1 for the treatment of HIV infections and hepatitis C.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs ITV 1 (Primary)
- Indications Hepatitis C; HIV infections
- Focus Registrational; Therapeutic Use
- Sponsors Immunotech Laboratories
- 09 Sep 2014 New trial record